Publisher: Icon Group International, Inc.
Category: Arthritis

Arthritis market research reports by Icon Group International, Inc.

(10 reports matching your criteria)
    • The 2025-2030 World Outlook for Bioelectric Medicines

      The 2025-2030 World Outlook for Bioelectric Medicines This study covers the world outlook for bioelectric medicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Osteoarthritis Treatments

      The 2025-2030 World Outlook for Osteoarthritis Treatments This study covers the world outlook for osteoarthritis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More

    • The 2025-2030 World Outlook for Psoriatic Arthritis Therapeutics

      The 2025-2030 World Outlook for Psoriatic Arthritis Therapeutics This study covers the world outlook for psoriatic arthritis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More

    • The 2025-2030 World Outlook for Osteoarthritis Drugs

      The 2025-2030 World Outlook for Osteoarthritis Drugs This study covers the world outlook for osteoarthritis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

    • The 2025-2030 World Outlook for Chiropractic Relief Care

      The 2025-2030 World Outlook for Chiropractic Relief Care This study covers the world outlook for chiropractic relief care across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Psoriatic Arthritis Treatments

      The 2025-2030 World Outlook for Psoriatic Arthritis Treatments This study covers the world outlook for psoriatic arthritis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More

    • The 2025-2030 World Outlook for Gout Therapeutics

      The 2025-2030 World Outlook for Gout Therapeutics This study covers the world outlook for gout therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More

    • The 2025-2030 World Outlook for Arthiritis Therapeutics

      The 2025-2030 World Outlook for Arthiritis Therapeutics This study covers the world outlook for arthiritis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More

    • The 2025-2030 World Outlook for Osteoarthritis Therapeutics

      The 2025-2030 World Outlook for Osteoarthritis Therapeutics This study covers the world outlook for osteoarthritis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More

    • The 2025-2030 World Outlook for Analgesic Osteoarthritis Treatments

      The 2025-2030 World Outlook for Analgesic Osteoarthritis Treatments This study covers the world outlook for analgesic osteoarthritis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings